Breaking News

Tweet TWEET

Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope

 Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and
                  Pharmacyclics Under StockCall's Microscope

PR Newswire

LONDON, March 13, 2013

LONDON, March 13, 2013 /PRNewswire/ --

The healthcare industry is adapting to the changing market dynamics. One of
the biggest trends in the industry has been President Obama's comprehensive
healthcare reform, Affordable Care Act (ACA). While ACA poses significant
challenges to drug manufacturers such as Warner Chilcott Plc (NASDAQ: WCRX),
Dynavax Technologies Corp. (NASDAQ: DVAX), ISIS Pharmaceuticals Inc. (NASDAQ:
ISIS), United Therapeutics Corp. (NASDAQ: UTHR), and Pharmacyclics Inc.
(NASDAQ: PCYC), another challenge for drug manufacturers has been increasing
competition from generics following the expiration of patents on several
blockbuster drugs in recent years. On Tuesday, healthcare stocks ended on a
mixed note as the broad market struggled after a week-long rally. StockCall
has released full comprehensive research on WCRX, DVAX, ISIS, UTHR, and PCYC
and these free technical analyses can be downloaded by signing up at

http://www.stockcall.com/technicalanalysis

Shares of Warner Chilcott Plc fell sharply in Tuesday's trading session. The
stock closed 1.10% lower at $13.46 on volume of 3.58 million. Despite the
sharp decline yesterday, the stock is still up more than 1% in the last three
sessions. Even as the healthcare industry faces challenges, Warner Chilcott's
shares have performed well this year, gaining nearly 12%, compared to a gain
of nearly 9% for the S&P 500. The stock is currently facing stiff resistance
at around $13.75. Free technical analysis on WCRX available by signing up at

http://www.StockCall.com/WCRX031313.pdf

Shares of Dynavax Technologies Corporation saw a huge rally in Tuesday's
trading session even as the broad market struggled. The stock ended the day
9.23% higher at $2.13 on volume of 3.29 million yesterday. In spite of
Tuesday's rally, Dynavax's shares have fallen more than 25% this year. The
stock broke through $2 resistance level yesterday, which is a bullish signal.
The upbeat trend is further confirmed by the stock's MACD chart. Register
today and access the free research on DVAX at

http://www.StockCall.com/DVAX031313.pdf

Shares of ISIS Pharmaceuticals Inc. rose sharply in Tuesday's session. The
stock closed 1.36% higher at $17.94 on volume of 1.21 million. ISIS
Pharmaceuticals shares have seen a series of highs in the last few trading
sessions, which is a strong bullish signal. The stock has also broken through
$15 resistance level. The optimistic trend is further confirmed by recent
volume activity and the stock's MACD chart. The free report on ISIS can be
downloaded by signing up now at

http://www.StockCall.com/ISIS031313.pdf

Shares of United Therapeutics Corp. posted modest gains in Tuesday's trading
session. The stock closed 0.64% higher at $62.49 on above average volume of
967,367. Yesterday, United Therapeutics' shares reached a 52-week high of
$62.61. The stock has had an excellent run in 2013, gaining nearly 17%. The
drug maker's shares have seen a series of highs in the last one month, which
is a strong bullish signal. The positive trend is further confirmed by recent
volume activity. Free report on UTHR can be accessed by registering at

http://www.StockCall.com/UTHR031313.pdf

Shares of Pharmacyclics Inc. fell sharply in Tuesday's trading session. The
stock closed 1.31% lower at $90.96 on above average volume of 897,740.
Pharmacyclics' shares are currently trading close to their 52-week high of
$95.85. The stock has fallen more than 3.70% in the last three trading
sessions. Register with StockCall and download the research on PCYC for free
at

http://www.StockCall.com/PCYC031313.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com 

SOURCE StockCall.com

Contact: Contact Person: William T. Knight, Email: info@stockcall.com ,
Contact Number: +1(646) 396-9857 (9:00 am EST - 01:30 pm EST)
 
Press spacebar to pause and continue. Press esc to stop.